Tubiana-Hulin M - Search Results

1

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution.

Tubiana-Hulin M, Stevens D, Lasry S, Guinebretière JM, Bouita L, Cohen-Solal C, Cherel P, Rouëssé J. Tubiana-Hulin M, et al. Ann Oncol. 2006 Aug;17(8):1228-33. doi: 10.1093/annonc/mdl114. Epub 2006 Jun 1. Ann Oncol. 2006. PMID: 16740599 Free article.

2

Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.

Le Scodan R, Stevens D, Brain E, Floiras JL, Cohen-Solal C, De La Lande B, Tubiana-Hulin M, Yacoub S, Gutierrez M, Ali D, Gardner M, Moisson P, Villette S, Lerebours F, Munck JN, Labib A. Le Scodan R, et al. Among authors: tubiana hulin m. J Clin Oncol. 2009 Mar 20;27(9):1375-81. doi: 10.1200/JCO.2008.19.5396. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204198

3

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression.

Briffod M, Spyratos F, Tubiana-Hulin M, Pallud C, Mayras C, Filleul A, Rouëssé J. Briffod M, et al. Cancer. 1989 Feb 15;63(4):631-7. doi: 10.1002/1097-0142(19890215)63:4<631::aid-cncr2820630405>3.0.co;2-w. Cancer. 1989. PMID: 2536583

4

[Chemotherapy of sarcomas in the adult].

Rouëssé J, Tubiana-Hulin M. Rouëssé J, et al. Bull Cancer. 1988;75(5):483-92. Bull Cancer. 1988. PMID: 3165036 French.

5

[Clinical prognostic factors in breast cancer. Retrospective study of 5609 cases].

Garbay JR, Hacène K, Tubiana-Hulin M, Yacoub S, Rouëssé J. Garbay JR, et al. Bull Cancer. 1994 Dec;81(12):1078-84. Bull Cancer. 1994. PMID: 7742596 French.

6

Sequential identification of factors predicting distant relapse in breast cancer patients treated by conservative surgery.

Tubiana-Hulin M, Le Doussal V, Hacene K, Rouëssé J, Brunet M. Tubiana-Hulin M, et al. Cancer. 1993 Aug 15;72(4):1261-71. doi: 10.1002/1097-0142(19930815)72:4<1261::aid-cncr2820720419>3.0.co;2-4. Cancer. 1993. PMID: 8393370

7

Dissemination risk index based on plasminogen activator system components in primary breast cancer.

Bouchet C, Hacène K, Martin PM, Becette V, Tubiana-Hulin M, Lasry S, Oglobine J, Spyratos F. Bouchet C, et al. J Clin Oncol. 1999 Oct;17(10):3048-57. doi: 10.1200/JCO.1999.17.10.3048. J Clin Oncol. 1999. PMID: 10506599

8

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up.

Spyratos F, Briffod M, Tubiana-Hulin M, Andrieu C, Mayras C, Pallud C, Lasry S, Rouëssé J. Spyratos F, et al. Cancer. 1992 Jan 15;69(2):470-5. doi: 10.1002/1097-0142(19920115)69:2<470::aid-cncr2820690233>3.0.co;2-l. Cancer. 1992. PMID: 1728376

9

[Chemotherapy of soft tissue sarcoma in adults].

Rouëssé J, Spielmann M, Le Chevalier T, Tubiana-Hulin M, Tursz T. Rouëssé J, et al. Bull Acad Natl Med. 1991 Nov;175(8):1251-9; discussion 1259-60. Bull Acad Natl Med. 1991. PMID: 1809496 Review. French.

10

[Treatment of bone and soft tissue sarcomas].

Rouëssé J, Tubiana-Hulin M. Rouëssé J, et al. Presse Med. 1991 Aug 31-Sep 7;20(27):1249-51. Presse Med. 1991. PMID: 1832758 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters